Phenoleptil Tafla 25 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

phenoleptil tafla 25 mg

dechra regulatory b.v. - phenobarbitalum inn - tafla - 25 mg

Librax Húðuð tafla Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

librax húðuð tafla

viatris aps - clidinii bromidum inn; chlordiazepoxidum inn - húðuð tafla

Uromitexan Stungulyf, lausn 100 mg/ml Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

uromitexan stungulyf, lausn 100 mg/ml

baxter medical ab* - mesnum inn - stungulyf, lausn - 100 mg/ml

Enrylaze Europska Unija - islandski - EMA (European Medicines Agency)

enrylaze

jazz pharmaceuticals ireland limited - crisantaspase - forvarnarfrumuæxli-eitilfrumuhvítblæði - Æxlishemjandi lyf - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.

Ezetrol Tafla 10 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

ezetrol tafla 10 mg

n.v. organon* - ezetimibum inn - tafla - 10 mg

Ezetimibe Alvogen (Ezetimibe ratiopharm) Tafla 10 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

ezetimibe alvogen (ezetimibe ratiopharm) tafla 10 mg

alvogen ehf. - ezetimibum inn - tafla - 10 mg

Neotigason Hart hylki 25 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

neotigason hart hylki 25 mg

teva b.v.* - acitretinum inn - hart hylki - 25 mg

Neotigason Hart hylki 10 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

neotigason hart hylki 10 mg

teva b.v.* - acitretinum inn - hart hylki - 10 mg

Ezetimib Medical Valley Tafla 10 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

ezetimib medical valley tafla 10 mg

medical valley invest ab - ezetimibum inn - tafla - 10 mg

Onsenal Europska Unija - islandski - EMA (European Medicines Agency)

onsenal

pfizer limited - celecoxib - adenomatous polyposis coli - Æxlishemjandi lyf - onsenal er ætlað til þess að fækka fjölda adenomatous þarmapólfa í fjölskyldufrumuæxli (fap) sem viðbót við skurðaðgerð og frekari eftirlitsskoðun (sjá kafla 4. Áhrif onsenal völdum lækkun g byrði á hættu á þarma krabbamein hefur ekki verið sýnt fram á (sjá kafla 4. 4 og 5.